The AAO-HNS Committee on Hearing and Equilibrium Guidelines for the diagnosis and evaluation of therapy in Meniere's disease: have they been applied in the published literature of the last decade?

Thorp, M. A.; Shehab, Z.P.; Bance, Manohar; Rutka, John

doi:10.1046/j.1365-2273.2003.00687.x

Cited by 45 publications

(43 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition, patients with mild symptoms may not have been diagnosed, as patients may suffer from variable auditory and/or vestibular symptoms for several years before they meet the diagnostic criteria for MD [da Costa et al, 2002]. Furthermore, Thorp et al [2003] observed that despite the existence of widely accepted diagnostic criteria, the majority of clinicians do not always adhere to them when making a diagnosis of MD. MD remains a difficult disease to diagnose, especially in the early stages when not all its symptoms are present [Sajjadi and Paparella, 2008].…”

Section: Discussionmentioning

confidence: 99%

Population-Based Study on the Epidemiology of Ménière's Disease

et al. 2017

View full text Add to dashboard Cite

Background and Objective: Ménière's disease (MD) is a disorder of the inner ear typically showing recurrent acute episodes of vertigo, hearing loss, and tinnitus. Epidemiologic studies on MD are scarce. We assessed the incidence rates (IRs) of MD and describe the characteristics of MD cases, comparing them to control patients without recorded evidence of MD. Study Design: We conducted a retrospective population-based follow-up study and a nested case-control analysis using data from the UK-based Clinical Practice Research Datalink. Methods: We identified patients between 18 and 79 years of age with an incident MD diagnosis between January 1993 and December 2014. We assessed the IRs of betahistine-treated MD. In the nested case-control analysis, we matched 4 controls to each MD case on sex, age, general practice, years of active history in the database, and calendar time. We conducted a χ² test to present p values in order to compare the prevalence of demographics, comorbidities, and co-medication between cases and controls. Results: We identified 5,508 MD cases and 22,032 MD-free controls (65.4% females). The overall IR for MD in the UK was 13.1 per 100,000 person-years. More cases were female, and the mean age at diagnosis was 55.4 ± 13.7 years. Smoking and alcohol consumption were less prevalent among MD cases. Depression, other affective disorders, sleeping disorders, anxiety, and migraine were more prevalent among MD cases than among controls. Conclusions: MD is uncommon in primary care in the UK with a preponderance among females.

show abstract

Section: Discussionmentioning

confidence: 99%

Population-Based Study on the Epidemiology of Ménière's Disease

et al. 2017

View full text Add to dashboard Cite

show abstract

“…In some cases, the results of the electorocochleogram and/or VEMP disagreed with clinical symptoms and disease history. The guidelines for M áeni àere's disease from the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) Committee of Hearing and Equilibrium dene M áeni àere's disease mostly in terms of its symptoms, 20,21 describing the probability of the disease as possible, probable, deˆnite, and certain. Certain M áeni àere's disease is deˆned as deˆnite with histopathologic conˆrmation; objective diagnosis with histological conˆrmation is currently virtually impossible.…”

Section: Magnetic Resonance In Medical Sciencesmentioning

confidence: 99%

Imaging Endolymphatic Hydrops at 3 Tesla Using 3D-FLAIR with Intratympanic Gd-DTPA Administration

et al. 2008

View full text Add to dashboard Cite

Purpose: Visualization of endolymphatic hydrops by 3-dimensional ‰uid-attenuated inversion recovery-FLAIR using conventional turbo-spin-echo (3D-FLAIR-CONV) after intratympanic injection of Gd-DTPA has been reported in patients with M áeni àere's disease. Compared to 3D-FLAIR-CONV used in previous studies, the addition of a variable ‰ip-angle technique (3D-FLAIR-VFL) enables very long echo trains and, therefore, shorter scan times. We evaluated whether 3D-FLAIR-VFL could replace 3D-FLAIR-CONV in detecting endolymphatic hydrops after intratympanic Gd-DTPA administration.Methods: Eleven patients were included in this study. Twenty-four hours after Gd-DTPA injection, we performed 3D-FLAIR-CONV and 3D-FLAIR-VFL imaging at 3T. We compared the contrast-to-noise ratio (CNR) between cochlear ‰uid and the cerebellum between the 2 FLAIR sequences. We subjectively scored the size of the endolymphatic space in the cochlea and vestibule for each patient and correlated the scores with the clinical diagnoses.Results: The CNR of 3D-FLAIR-CONV was signiˆcantly higher than that of 3D-FLAIR-VFL. Scores for the size of endolymphatic space in the vestibule were identical between the 2 sequences; however, those in the cochlea disagreed in 3 cases. 3D-FLAIR-CONV correlated better with the clinical diagnoses.Conclusions: Currently, we may not be able to replace 3D-FLAIR-CONV with 3D-FLAIR-VFL, at least not with the scanning parameters used in the present study.

show abstract

“…An assessment of the application of the AAO-HNS guidelines for MD diagnosis across the published literature from 1989 to 1999 showed that 80% of studies used the guidelines, but that <40% used them correctly [Thorp et al, 2003]. Bauer et al [2015] altered the diagnostic inclusion criteria, including the number and type of encounter, and found a reduction in prevalence of up to 35% when using the most restrictive criteria compared to the broadest.…”

Section: Introductionmentioning

confidence: 99%

Exploring Methods to Measure the Prevalence of Ménière's Disease in the US Clinformatics™ Database, 2010-2012

Ricchetti-Masterson¹,

Aldridge²,

Logie³

et al. 2016

Audiol Neurotol

View full text Add to dashboard Cite

Recent studies on the epidemiology of the inner-ear disorder Ménière's disease (MD) use disparate methods for sample selection, case identification and length of observation. Prevalence estimates vary geographically from 17 to 513 cases per 100,000 people. We explored the impact of case detection strategies and observation periods in estimating the prevalence of MD in the USA, using data from a large insurance claims database. Using case detection strategies of ≥1, ≥2 and ≥3 ICD-9 claim codes for MD within a 1-year period, the 2012 prevalence estimates were 66, 27 and 14 cases per 100,000 people, respectively. For ≥1, ≥2 and ≥3 insurance claims within a 3-year observation period, the prevalence estimates were 200, 104 and 66 cases per 100,000 people, respectively. Estimates based on a single claim are likely to overestimate prevalence; this conclusion is aligned with the American Academy of Otolaryngology-Head and Neck Foundation criteria requiring ≥2 definitive episodes for a definite diagnosis, and it has implications for future epidemiologic research. We believe estimates for ≥2 claims may be a more conservative estimate of the prevalence of MD, and multiyear estimates may be needed to allow for adequate follow-up time.

show abstract

The AAO-HNS Committee on Hearing and Equilibrium Guidelines for the diagnosis and evaluation of therapy in Meniere's disease: have they been applied in the published literature of the last decade?

Cited by 45 publications

References 6 publications

Population-Based Study on the Epidemiology of Ménière's Disease

Population-Based Study on the Epidemiology of Ménière's Disease

Imaging Endolymphatic Hydrops at 3 Tesla Using 3D-FLAIR with Intratympanic Gd-DTPA Administration

Exploring Methods to Measure the Prevalence of Ménière's Disease in the US Clinformatics™ Database, 2010-2012

Contact Info

Product

Resources

About